clinical trial · NCT07190755
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Centre Henri Becquerel·N/A·recruiting·n = 192
Head and Neck Squamous Cell Carcinoma HNSCCRemote symptoms moniotring
brief summary
The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.
started
Oct 15, 2025
primary completion
Jun 1, 2030
completion
Jun 1, 2030
last updated
Dec 30, 2025
official title
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Curative Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) With Radiotherapy or Chemoradiotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol